Singapore markets closed

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
105.38+2.83 (+2.76%)
At close: 04:00PM EDT
105.28 -0.10 (-0.09%)
Pre-market: 09:15AM EDT
Show:
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
157,251,000
140,800,000
126,946,000
122,021,000
111,831,000
Cost of revenue
25,286,000
23,658,000
20,932,000
20,088,000
17,617,000
Gross profit
131,965,000
117,142,000
106,014,000
101,933,000
94,214,000
Operating expenses
Research development
20,213,000
17,772,000
15,462,000
14,220,000
14,805,000
Selling general and administrative
45,949,000
41,058,000
36,886,000
35,830,000
33,313,000
Total operating expenses
65,544,000
58,498,000
51,888,000
49,450,000
46,966,000
Operating income or loss
66,421,000
58,644,000
54,126,000
52,483,000
47,248,000
Interest expense
4,230,000
289,000
390,000
220,000
85,000
Total other income/expenses net
-
616,000
-793,000
-3,494,000
473,000
Income before tax
62,939,000
59,080,000
53,130,000
48,553,000
47,615,000
Income tax expense
12,400,000
11,323,000
10,992,000
9,602,000
8,987,000
Income from continuing operations
50,539,000
47,757,000
42,138,000
38,951,000
38,628,000
Net income
50,539,000
47,757,000
42,138,000
38,951,000
38,628,000
Net income available to common shareholders
50,539,000
47,757,000
42,138,000
38,951,000
38,628,000
Basic EPS
-
20.79
18.05
16.41
15.96
Diluted EPS
-
20.74
18.01
16.38
15.93
Basic average shares
-
2,297,114
2,333,900
2,374,299
2,419,603
Diluted average shares
-
2,302,652
2,340,000
2,378,658
2,424,417
EBITDA
-
65,394,000
59,273,000
54,434,000
51,625,000